Journal of Global Oncology
Overview
Journal of Global Oncology is a scientific journal, published since 2015 in English. The journal's country of origin is United States and its primary focus area is oncology.
Details
Details
Abbr.
J Glob Oncol
Start
2015
End
2019
Frequency
Bimonthly
e-ISSN
2378-9506
Country
United States
Language
English
Specialty
Oncology
Recent Articles
1.
2.
Salama M, Ataman-Millhouse L, Sobral F, Terrado G, Scarella A, Bourlon M, et al.
J Glob Oncol
. 2020 Apr;
4.
PMID: 32259158
Purpose: Oncofertility practice continues to grow in developing countries despite the lack of health care services, especially those related to cancer care. The purpose of this study is to further...
3.
Shiraishi E, Sugimoto K, Shapiro J, Ito Y, Kamoshita K, Kusuhara A, et al.
J Glob Oncol
. 2020 Apr;
4.
PMID: 32259157
Purpose: The oncofertility decision tree was developed by the oncofertility consortium as a tool to support healthcare professionals and patients through the complicated process of deciding the most appropriate fertility...
4.
Salama M, Ataman L, Taha T, Azmy O, Braham M, Douik F, et al.
J Glob Oncol
. 2020 Apr;
4.
PMID: 32259156
Purpose: Little is known about oncofertility practice in developing countries that usually suffer from a shortage of health services, especially those related to cancer care. Materials And Methods: To learn...
5.
Vargas V, Leopold C, Castillo-Riquelme M, Darrow J
J Glob Oncol
. 2019 Dec;
5:1-17.
PMID: 31860377
Purpose: The population of Chile has aged, and in 2017, cancer became the leading cause of death. Since 2005, a national health program has expanded coverage of drugs for 13...
6.
McCann E, Fuentes-Alabi S, Antillon F, Vega-Vega L, Sanchez M, Albanti I
J Glob Oncol
. 2019 Dec;
5:1-10.
PMID: 31834833
Methods: A qualitative study involving 72 in-person interviews and 4 focus groups was conducted using a semistructured interview guide. Key informants included family members, physicians, nurses, psychosocial providers, foundation leadership,...
7.
Seshachalam A, Karpurmath S, Rathnam K, Raman S, Janarthinakani M, Prasad K, et al.
J Glob Oncol
. 2019 Dec;
5:1-13.
PMID: 31834832
Purpose: Escalated BEACOPP (bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone) improves overall survival (OS) in patients with Hodgkin lymphoma (HL) relative to ABVD (doxorubicin, bleomycin, vinblastine, and dacarbazine) therapy....
8.
Rick T, Habtamu B, Tigeneh W, Abreha A, van Norden Y, Grover S, et al.
J Glob Oncol
. 2019 Dec;
5:1-8.
PMID: 31834831
Purpose: Radiotherapy (RT) is an essential component of cancer treatment. There is a lack of RT services in sub-Saharan Africa as well as limited knowledge regarding clinical practices. The purpose...
9.
Ezeani A, Odedina F, Rivers D, Fatiregun O, Akinremi T
J Glob Oncol
. 2019 Dec;
5:1-7.
PMID: 31809225
Cancer is rapidly becoming a public health crisis as a result of the continued growth and ageing of the global population and will greatly affect resource-limited low- to middle-income countries....
10.
Viswabandya A, Shah S, Mukhopadhyay A, Nagarkar R, Batra S, Lopez-Lazaro L, et al.
J Glob Oncol
. 2019 Dec;
5:1-13.
PMID: 31809224
Purpose: We sought to compare the pharmacokinetics (PKs) of DRL-rituximab (DRL_RI; potential biosimilar) and innovator rituximab MabThera (Roche, Grenzach-Wyhlen, Germany; reference medicinal product [RMP]) in patients with diffuse large B-cell...